Last updated:
Author(s):
Kai Shi Lim, Maria Teresa Periñan, Elaine Guo Yan Chew, Paul Suhwan Lee, Fulya Akçimen, Jia Lun Lim, Mathew J. Koretsky, Manabu Funayama, Hiroyo Yoshino, Nobutaka Hattori, Rauan Kaiyrzhanov, Henry Houlden, Mariam Isayan, Yi Wen Tay, Tzi Shin Toh, Lei-Cheng Lit, Anis Nadhirah Khairul Anuar, Hans Xing Ding, Laurel Screven, Norlinah Mohamed Ibrahim, Chin-Hsien Lin, Han-Joon Kim, Jee-Young Lee, Sun Ju Chung, Jia Nee Foo, Eng-King Tan, Shen-Yang Lim, Ai Huey Tan, Sara Bandres-Ciga, Azlina Ahmad-Annuar
Publish date:
2 February 2026
Journal:
npj Parkinson's Disease
PubMed ID:
41629305

Abstract

Common and rare variants in LRRK2 influence Parkinson’s disease (PD) risk across diverse populations, and in this study, the rare p.A419V variant was investigated across multiple ancestry cohorts comprising over 200,000 PD cases and controls. In cases of East Asian (EAS) ancestry, p.A419V was significantly associated with increased risk of PD (OR = 2.9; 95% CI: 1.66-5.10; p = 0.0002), and was not in linkage disequilibrium with other LRRK2 coding variants. The variant was significantly associated with a lower age at PD onset in the study cohort, while a meta-analysis of the EAS cases indicated a similar, albeit non-significant trend. LRRK2 protein modelling prediction indicated that binding sites for RAB8A, RAB29 and RAB32 were in close proximity to the p.A419V variant within the ARM domain. Together, these findings confirm the p.A419V as a significant PD risk factor in EAS populations, as well as highlight disease-relevant variants in the ARM domain and the link with LRRK2-RAB signaling.

Related projects

Neurodegenerative diseases (e.g. Alzheimer?s disease and Parkinson?s disease) are a major healthcare burden and the prevalence is predicted to increase significantly with the aging population.

Institution:
National Institute on Aging, United States of America

All projects